📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Wearable Injectors Market Trends

ID: MRFR//5029-HCR | 100 Pages | Author: Kinjoll Dey| July 2024

Wearable Injectors Market Overview 

Wearable Injectors Market Size was valued at USD 15.43 Billion in 2023. The Wearable Injectors industry is projected to grow from USD 19.87 Billion in 2024 to USD 23.76 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 19.09% during the forecast period (2024 - 2032). believes Market Research Future (MRFR). The shift in healthcare delivery toward homecare as a result of COVID-19, the advantages of wearable injectors in the administration of various drugs, the rising prevalence of chronic diseases (such as cancer, diabetes, and CVD), favorable reimbursement scenarios in major markets, and technological advancements in injector devices are all driving growth in this market.

The COVID-19 pandemic's uncertainty has influenced the demand for various therapeutics and wearable drug delivery technologies. Healthcare systems around the world took steps to postpone treatments for diseases like cancer to prevent the spread of the infection and safeguard high-risk patients from infection.

The hazards for individuals receiving care rose as the pandemic began. Hospitals, which serve the bulk of patients, also became high-risk areas during the epidemic. To address these issues and provide appropriate care to patients suffering from various ailments, a movement from hospital-based care to home-based care has occurred. The rising frequency of chronic diseases, technology breakthroughs, design development, increased concern about the dangers of needlestick injuries, and the restrictions on drug delivery with a simple syringe are all factors driving market expansion.

By June 2023, Stevanato had revealed that they are partnering with Thermo Fisher Scientific to launch VertivaTM for the on-body delivery system.

On May 2023, Medtronic announced its plan to acquire EOFlow’s wearable injector EOPatch®.

Viridian Therapeutics partnered with Enable Injections in May 2023 to test their enFuse wearable injector technology for early-stage drug candidates. Additionally, developers of these devices have also been working together with contract manufacturer organizations so as to enter into the marketplace and meet the growing demand for on-body injectors.

Enable Injections, Inc. collaborated with Viridian Therapeutics, Inc., a U.S.-based biotechnology company in May 2023.

In March 2023, Stevanato Group entered into one such collaboration with Thermo Fisher Scientific; under this arrangement, Stevanato provided pre-sterilized EZ-fill cartridges and assembly equipments while Thermo Fisher Scientific offered fill finish and final assembly services.

Wearable Injectors Market Segment Insights

The wearable injectors market has been segmented into type, usage, mechanism of action, therapeutic area, and end-user.

The wearable injectors market, on the basis of type, has been segmented into on-body wearable injectors, off-body wearable injectors, and hand-held wearable injectors.

The wearable injectors market, by usage, has been segmented into disposable and semi-reusable.

The market, by mechanism of action, has been segmented into spring based, motor driven, rotary pump, expanding battery, pressurized gas, and collapsible reservoir.

The market, by therapeutic area, has been segmented into oncology, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetes, and others.

The market, by end-user, has been segmented into hospitals, clinics, homecare, ambulatory surgery centers, others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The wearable injectors market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European wearable injectors market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The wearable injectors market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The wearable injectors market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

are some of the key players in the wearable injectors market.

Regional Market Summary

Wearable Injectors Market Share (%), by Region

Geographically, the Americas is anticipated to dominate the wearable injectors market owing to a well-developed healthcare sector, rising prevalence of autoimmune and chronic disease and growing healthcare expenditure. According to a report published by American Autoimmune Related Diseases Association (AARDA) in April 2017, in the US approximately 50 million people i.e. nearly 20% population suffer from autoimmune diseases. Additionally, government funding in this region contributes to the growth of the market.

Europe is expected to hold the second largest position in the wearable injectors market. The market growth in this region is attributed to the growing prevalence of chronic diseases, the availability of funds for research, and increasing healthcare expenditure. According to a report published by the NSD Alliance in July 2017, 1/3rd of the European population above the age of 15 years suffer from a chronic disease.

Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population, continuously developing economies, rising prevalence of chronic diseases like diabetes, cardiovascular diseases and increasing government funding for the healthcare sector. According to a study published in the Asian Pacific Journal of Tropical Biomedicine journal in 2014, it was estimated that about 150 million diabetic patients reside within the region, out of which more than 95% have type 2 diabetes mellitus.

On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.

Recent Development

BD (Becton, Dickinson, and Company) released the results of a 52-subject human clinical trial with the BD Libertas Wearable Injector in August 2021. The ready-to-use subcutaneous drug delivery system, which is now in the final stages of research, is designed to deliver pharmaceuticals such as biologics with viscosities up to 50 cP in 2-5 mL and 5-10 mL configurations. TruPharma LLC and its marketing and development partner Sage Chemical Inc. confirm that the US Food and Drug Administration has approved the latter's Abbreviated New Drug Application for generic apomorphine hydrochloride cartridges in March 2022. The USFDA approved the generic cartridge product after determining that it is therapeutically equivalent and bioequivalent to the reference listed drug APOKYN branded Injection, which is used by injection to treat patients with advanced Parkinson's disease.

Wearable Injectors Market Segmentation

Wearable Injectors Type Outlook

  • On-Body Wearable Injectors

  • Off-Body Wearable Injectors

  • Hand Held Wearable Injectors

Wearable Injectors Usage Outlook

  • Disposable Wearable Injectors

  • Semi-Reusable Wearable Injectors

Wearable Injectors Mechanism of Action Outlook

  • Spring Based

  • Motor Driven

  • Rotary Pump

  • Expanding Battery

  • Pressurized Gas

  • Collapsible Reservoirs

Wearable Injectors Therapeutic Area Outlook

Wearable Injectors End User Outlook

  • Hospitals

  • Clinics

  • Home Care

  • Ambulatory Surgery Centers

  • Others

Wearable Injectors Region Outlook

  • Americas

    • North America

    • US

    • Canada

    • South America

  • Europe

    • Western Europe

    • Germany

    • France

    • Italy

    • Spain

    • UK

    • Rest of Western Europe

    • Eastern Europe

  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific

  • Middle East & Africa

    • Middle East

    • Africa 

Intended Audience

  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institute

  • Academic Institutes and Universities

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.